Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000169162 | SCV000220390 | likely pathogenic | Alpha-1-antitrypsin deficiency | 2014-06-06 | criteria provided, single submitter | literature only | |
Labcorp Genetics |
RCV000169162 | SCV001232395 | pathogenic | Alpha-1-antitrypsin deficiency | 2024-01-19 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Lys241*) in the SERPINA1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SERPINA1 are known to be pathogenic (PMID: 25425243). This variant is present in population databases (rs199422211, gnomAD 0.004%). This premature translational stop signal has been observed in individuals with SERPINA1-related conditions (PMID: 3257351, 26321041). This variant is also known as p.Lys217* and "Null Bellingham". ClinVar contains an entry for this variant (Variation ID: 17977). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000169162 | SCV004203135 | pathogenic | Alpha-1-antitrypsin deficiency | 2024-02-06 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000019581 | SCV000039878 | other | PI NULL(BELLINGHAM) | 2016-07-15 | no assertion criteria provided | literature only | |
OMIM | RCV000019582 | SCV000039879 | other | PI Q0(BELLINGHAM) | 2016-07-15 | no assertion criteria provided | literature only | |
Department of Laboratory Medicine and Genetics, |
RCV000169162 | SCV000608325 | pathogenic | Alpha-1-antitrypsin deficiency | 2014-12-08 | no assertion criteria provided | curation | |
Diagnostic Laboratory, |
RCV001528835 | SCV001741251 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001528835 | SCV001965583 | pathogenic | not provided | no assertion criteria provided | clinical testing |